Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1016/j.vaccine.2010.03.029
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: ; Search for: 1
Affiliation
  1. National Research Council of Canada. NRC Biotechnology Research Institute
FormatText, Article
Subjectacids; activity; biotechnology; adenovirus; apoptosis; bioreactor; cell culture; cell death; cell line; cell; centrifugation; chromatography; comparative study; gene expression; gene therapy; gene; glycosylation; HEK-293; HEK-293 cells; hemagglutinin; in vitro; influenza; influenza vaccine; influenza virus; insect cell; iodixanol; kidney; kinetics; metabolism; morphogenesis; neuraminidase; nucleic acids; oxygen; protein; protein production; purification; recombinant protein; recombinant proteins; RNA; scalable processes; serum-free medium; suspension culture; synthesis; therapy; transfection; vaccine production; virology; virulence; virus production; virus replication; vitro
Abstract
Publication date
In
LanguageEnglish
Peer reviewedYes
NRC numberNRCC 52752
NPARC number16225341
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier708c5796-3c2c-4ca2-ae94-4437c91b1829
Record created2010-11-05
Record modified2020-04-17
Date modified: